Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
COVID-19
100%
Hypertension
100%
Pediatric Nephrology
91%
Nephrotic Syndrome
66%
Kidney Transplantation
47%
Target Organ
36%
Bartter Syndrome
36%
Urea
36%
Pediatrics Patient
33%
Urinary Tract Infection
33%
Bardet-Biedl Syndrome
33%
Diverticulum
33%
Solitary Kidney
33%
Congenital Rubella Syndrome
33%
Heart Performance
33%
Hypogammaglobulinemia
33%
Arterial Stiffness
33%
Nephrocalcinosis
33%
Retrospective Study
33%
Rituximab
33%
Toll Like Receptor 4
33%
Kidney Stone
33%
Streptococcus Pneumonia
33%
Subacute Sclerosing Panencephalitis
33%
Pneumococcal Pneumonia
33%
Purpura fulminans
33%
Kidney Dysplasia
33%
Peritoneal Dialysis
33%
Fibroblast Growth Factor 23
33%
Autosomal Recessive Polycystic Kidney Disease
33%
Radiodiagnosis
33%
Adolescence
33%
White Coat Hypertension
33%
Steroid
32%
Spontaneous Remission
27%
QT Dispersion
26%
Isotopes of Calcium
26%
Kt/V
25%
Fibroblast
25%
Cataract
25%
Parathyroid Hormone
25%
Infection
20%
Blood Pressure Monitoring
19%
ACE Inhibitor
16%
Calcium Channel Blocking Agent
16%
Posterior Urethral Valve
16%
Rod-Cone Dystrophy
16%
Ciliopathy
16%
Proteinuria
16%
Kidney Malformation
16%
Keyphrases
COVID-19
66%
Pediatric Nephrology
53%
Dialysis
53%
Young-onset Hypertension
50%
Nephrotic Syndrome
33%
Nephrology Practice
33%
Nephrology Education
33%
Coronavirus Impact
33%
Pediatric Hypertension
33%
Kidney Transplantation
33%
Urea
33%
American Academy of Pediatrics
33%
Pediatric Patients
33%
Unilateral Renal Agenesis
33%
Ureteral Diverticulum
33%
Measles
33%
Subacute Sclerosing Panencephalitis
33%
International Participation
33%
Peritoneal Dialysis
33%
Turkish children
33%
Calcium Channel Blockers
33%
Urolithiasis
33%
Large Case Series
33%
Urinary Tract Infections in children
33%
Chronic Dialysis
33%
Fibroblast Growth Factor 23 (FGF23)
33%
Fibroblasts
33%
Hypogammaglobulinemia
33%
Hypertensive Patients
33%
Iron-replete
33%
Nephrocalcinosis
33%
Angiotensin-converting Enzyme Inhibitor (ACEi)
33%
Chronic Kidney
33%
Damage Test
33%
Rituximab
33%
Group Studies
33%
Left Ventricle Geometry
33%
White-coat Hypertension
33%
Enuresis
33%
Monosymptomatic
33%
Metabolic Risk Factors
30%
25(OH) Vitamin D
22%
1,25(OH)2 Vitamin D
22%
Intact Parathyroid Hormone (iPTH)
22%
Microlithiasis
20%
Remission Rate
20%
Obese children
16%
Hypertension
16%
European Society of Hypertension
16%
Early Onset
16%
